The multipathogen profiles and co-infection characteristics obtained from comprehensive surveillance of patients with acute respiratory infections in the post-COVID-19 era in Shenzhen, China.

The multipathogen profiles and co-infection characteristics obtained from comprehensive surveillance of patients with acute respiratory infections in the post-COVID-19 era in Shenzhen, China.

Publication date: Dec 17, 2025

The long-term impact of the COVID-19 pandemic on the distribution pattern of respiratory pathogens in China was unknown. Our study aimed to determine the multipathogen profiles and co-infection characteristics among patients with acute respiratory infections (ARIs) in the post-COVID-19 era in Shenzhen, China. This multi-center cross-sectional study was conducted among patients with ARIs from five sentinel hospitals from November 1, 2022 to June 30, 2023 in Shenzhen, China. The collected respiratory samples were subjected to targeted next-generation sequencing for high-throughput screening of 108 respiratory pathogens. Multi-stage logistic regression models were built to infer interactions between pathogens at the individual level. The median [IQR] age of 1890 patients included was 31. 8 [23. 7, 45. 2] years. The proportions of positivity on any pathogen and co-infection were 84. 0% (1587/1890) and 41. 4% (782/1890). Children 

Open Access PDF

Concepts Keywords
China Acute respiratory infections
Hospitals Co-infection
June Comprehensive surveillance
Pandemic Pathogen profiles
Post-COVID-19 era

Semantics

Type Source Name
disease MESH co-infection
disease MESH respiratory infections
disease MESH COVID-19
disease MESH included
disease MESH Infectious Diseases
disease MESH Dis
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Guanosine
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH Park
disease MESH Influenza
disease MESH parainfluenza
disease MESH pneumonia
disease MESH fever
disease MESH emergency
disease MESH respiratory diseases
disease MESH asthma
pathway KEGG Asthma
disease MESH tumors
disease MESH pleural effusion
drug DRUGBANK Isoxaflutole

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *